Literature DB >> 10530443

Impact of bacterial pneumonia and Pneumocystis carinii pneumonia on human immunodeficiency virus disease progression. Pulmonary Complications of HIV Study Group.

D H Osmond1, D P Chin, J Glassroth, P A Kvale, J M Wallace, M J Rosen, L B Reichman, W K Poole, P C Hopewell.   

Abstract

The course of pneumonia caused by pyogenic bacteria and Pneumocystis carinii was examined in a multicity cohort study of HIV infection. The median duration of survival among 150 individuals following initial bacterial pneumonia was 24 months, compared with 37 months among 299 human immunodeficiency virus (HIV)-infected control subjects matched by study site and CD4 lymphocyte count (P<.001). For 152 subjects with P. carinii pneumonia, median survival was 23 months, compared with 30 months for 280 matched control subjects (P = .002). Median durations of survival associated with the two types of pneumonia differed by only 47 days, despite a higher median CD4 lymphocyte count associated with bacterial pneumonia. These results suggest that both P. carinii pneumonia and bacterial pneumonia are associated with a significantly worse subsequent HIV disease course. The similarity of prognosis after one episode of bacterial pneumonia vs. an AIDS-defining opportunistic infection and the proportion of cases occurring in association with a CD4 lymphocyte count of >200 suggest that measures to prevent bacterial pneumonia should be emphasized.

Entities:  

Mesh:

Year:  1999        PMID: 10530443     DOI: 10.1086/598629

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  4 in total

Review 1.  HIV-1 and bacterial pneumonia in the era of antiretroviral therapy.

Authors:  Leopoldo N Segal; Barbara A Methé; Anna Nolan; Yoshihiko Hoshino; William N Rom; Rod Dawson; Eric Bateman; Michael D Weiden
Journal:  Proc Am Thorac Soc       Date:  2011-06

Review 2.  Rapid diagnosis of pneumococcal pneumonia among HIV-infected adults with urine antigen detection.

Authors:  David R Boulware; Charles L Daley; Cynthia Merrifield; Philip C Hopewell; Edward N Janoff
Journal:  J Infect       Date:  2007-08-10       Impact factor: 6.072

3.  The effect of opportunistic illness on HIV RNA viral load and CD4+ T cell count among HIV-positive adults taking antiretroviral therapy.

Authors:  John P Ekwaru; James Campbell; Samuel Malamba; David M Moore; Willy Were; Jonathan Mermin
Journal:  J Int AIDS Soc       Date:  2013-04-01       Impact factor: 5.396

Review 4.  Clinical review: Respiratory failure in HIV-infected patients--a changing picture.

Authors:  Putul Sarkar; Husham F Rasheed
Journal:  Crit Care       Date:  2013-06-14       Impact factor: 9.097

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.